During the last decade, the incidence of new HIV infections declined markedly. However, it is estimated that 35 million people are still living with HIV around the globe, and in 2014, two-thirds of these people were living in sub-Saharan Africa where food insecurity remained an issue (Joint United Nations Programme on HIV/AIDS, 2014).
Micronutrient deficiencies are common in people with HIV (Visser et al., 2017) , particularly in lowincome countries where diets may be low in essential vitamins and minerals. Micronutrient deficiencies may be more pronounced in people with advanced HIV as a result of reduced dietary intake, opportunistic infections, diarrhea, and parasitic infections (Visser et al., 2017) .
Micronutrients are critical to immune function. Studies conducted prior to the introduction of antiretroviral therapy (ART) suggested that micronutrient deficiencies might hasten HIV progression (Graham et al., 1991; Kupka et al., 2004) . Later studies have also demonstrated an association between vitamin D deficiencies and disease progression for adults with HIV on ART (Aziz et al., 2013; Ross et al., 2011) . Vitamin and/or mineral supplementation may benefit people living with HIV (PLWH) by strengthening their immune systems and helping them to recover from infections more quickly (Visser et al., 2017) . However, a robust evidence base is needed to guide health care policy and practice.
Objective
The objective of this Cochrane review was to assess whether micronutrient supplements are effective and safe in reducing morbidity and mortality in PLWH.
Intervention/Methods
The review was an update of a Cochrane review published in 2010 (Irlam et al., 2010) . Literature searches were, therefore, undertaken from January 
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Mortality from any cause. Morbidity-episodes of opportunistic infections, progression to AIDS, hospital admissions, and other illnesses related to HIV infection. Disease progression.
Secondary outcome measures included:
Virologic response-proportion of participants who maintained an undetectable viral load and changes in HIV-RNA levels. Virologic failure-proportion of participants who discontinued or changed ART due to virologic failure. Immune response markers. Nutritional status-measures such as body weight, body mass index, and body composition. Biochemical markers, including serum micronutrient concentrations.
Results
Thirty-three randomized controlled trials with 10,325 participants were included in the review. Participants in 19 of the trial participants were on ART, and in 13 of the trials, were not on ART. None of the trials that used single or dual micronutrient supplements were adequately powered to determine impact on HIV-related mortality or morbidity. Additionally, no clinically significant changes in CD41 T cell counts or HIV viral loads were identified. However, in one trial, peripheral neuropathy was lower in participants with high-dose supplements, but that study was stopped early due to adverse events.
Conclusions
The review aimed to determine whether micronutrient supplements containing vitamins or minerals or both were effective and safe in reducing morbidity or mortality for PLWH, whether they were on ART or not. The results were inconclusive, as none of the trials were adequately powered to identify impact on mortality or morbidity.
Implications for Practice
Because a number of adult PLWH experience micronutrient deficiencies, it is important to consider whether supplementation with vitamins and/or minerals may be a safe and effective way to reduce disease progression or number of deaths. However, because the trials included in this review were small and underpowered, it was not possible to make clinical recommendations. Visser et al. (2017) did note that, for people with nutritional deficiencies or whose diets did not include the recommended daily allowance of vitamins and minerals, micronutrient supplementation should not be withheld based on the findings of this review.
